Literature DB >> 2893060

Combination therapy after retroviral inoculation.

R M Ruprecht, M A Gama-Sosa, H D Rosas.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 2893060     DOI： 10.1016/s0140-6736(88)91087-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome.

Authors:  N S Zeidner; M H Myles; C K Mathiason-DuBard; M J Dreitz; J I Mullins; E A Hoover
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

2.  Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection.

Authors:  K Mori; Y Yasutomi; S Sawada; F Villinger; K Sugama; B Rosenwith; J L Heeney; K Uberla; S Yamazaki; A A Ansari; H Rübsamen-Waigmann
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Protective cellular retroviral immunity requires both CD4+ and CD8+ immune T cells.

Authors:  R C Hom; R W Finberg; S Mullaney; R M Ruprecht
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

4.  Vaccination with a live retrovirus: the nature of the protective immune response.

Authors:  R M Ruprecht; S Mullaney; L D Bernard; M A Gama Sosa; R C Hom; R W Finberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.